MALAT1 was significantly overexpressed in the study cohort compared to the normal controls, which is consistent with recent studies linking MALAT1 overexpression with significantly increased cell proliferation and invasion in ovarian cancer [36, 37]. Here, MALAT1 is linked to ovarian carcinoma.